Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 7Completed 7Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Tumor-Agnostic 3Other hematologic neoplasm 3Breast 3Genitourinary 2Thoracic 1Other solid neoplasm 1Other 1Head & Neck 1Dermatologic 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

pembrolizumab 26Cisplatin 15Pemetrexed 14Paclitaxel 14Carboplatin 14Nivolumab 10Cyclophosphamide 10Docetaxel 8atezolizumab 7Injections 7Melphalan 6tislelizumab 5olaparib 5Gemcitabine 5Filgrastim 5durvalumab 4aldesleukin 4Leucovorin 4Irinotecan 4Granulocyte Colony-Stimulating Factor 4Etoposide 4Bevacizumab 4tocilizumab 3spartalizumab 3liposomal doxorubicin 3ixabepilone 3fludarabine 3epacadostat 3defactinib 3adavosertib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Methods × Other solid neoplasm × Clear all
NCT02895490 2016-09-20

Communication Training in Promoting Employment Retention Among Cancer Patients

Virginia Commonwealth University

Phase NA Terminated
8 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡